Search Results for

Showing 11 - 20 of 80 results
  1. AMPC Candidates

    All candidate bios and nomination statements are available on the official ballots

  2. Board of Trustees

    Board of Trustees The Board of Trustees is comprised of elected members from ARVO's 13 Scientific Sections along with elected and trustee-appointed officers. The president and vice president(s) are elected from within the Board each year. The executive vice president is elected by the general membership to a five-year term and is a voting member of the Board of Trustees. The ARVO executive director serves as an ex officio member of the Board. For more information on Board of Trustee duties,

  3. Spotlight on members: Spark

    Spotlight on members From hospital funding to FDA approval Spark Therapeutics develops gene therapy for inherited retinal blindness After over two decades of research and development in gene therapy, Katherine A. High, MD, co-founder, president and chief scientific officer of Spark Therapeutics, is breathing a big sigh of relief this fall. On Oct. 12, the Food and Drug Administration unanimously voted to approve voretigene neparvovec, Spark Therapeutics' gene therapy treatment for inherited b

  4. Journals and Publications landing

    Journals and Publications ARVO Journals           Visit the ARVO Funding Guide and search through 200+ funding opportunities in the fields of eye and vision research.  ARVO Funding Guide ARVONews ARVO Insight

  5. China

    International Advocacy Toolkit: China Organizing Questions Which organization/s are significant sources of research funding?  What does the normal science funding/policy decision-making process look like? Which patient advocacy groups, if any, are active in the area? Are there existing national/regional organizations that work towards improving research funding/policy? How do scientists currently contribute to the existing funding/policy-making/advocacy process, if at all?  When are

  6. Brazil

    International Advocacy Toolkit: Brazil Organizing Questions Which organization/s are significant sources of research funding?  What does the normal science funding/policy decision-making process look like? Which patient advocacy groups, if any, are active in the area? Are there existing national/regional organizations that work towards improving research funding/policy? How do scientists currently contribute to the existing funding/policy-making/advocacy process, if at all?  When ar

  7. Japan

    International Advocacy Toolkit: Japan Organizing Questions Which organization/s are significant sources of research funding?  What does the normal science funding/policy decision-making process look like? Which patient advocacy groups, if any, are active in the area? Are there existing national/regional organizations that work towards improving research funding/policy? How do scientists currently contribute to the existing funding/policy-making/advocacy process, if at all?  When are

  8. MIN

    Members in the News Champalimaud MiN

  9. MIN

    Members in the News Champalimaud MiN